Human Molecular Genetics Advance Access published online on April 28, 2004
Human Molecular Genetics, doi:10.1093/hmg/ddh138
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Reta Lila Weston Institute of Neurological Studies, University College London, Windeyer Building, 46 Cleveland Street, London, W1T 4JF; Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N 3BG, UK
* To whom correspondence should be addressed. E-mail: rsilva{at}ion.ucl.ac.uk.
The group of neurodegenerative diseases collectively known as tauopathies are characterised by hallmark lesions consisting of fibrillar aggregates of the microtubule associated protein, tau. Mutations of the tau gene (MAPT) are the cause of frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) giving tau a central role in the pathogenic process. The chromosomal region containing MAPT has been shown to have evolved into two major haplotypes, H1 and H2 which are defined by linkage disequilibrium (LD) between several polymorphisms over the entire MAPT gene. Studies to date suggest a complete absence of recombination between these two haplotypes. The more common haplotype H1 is over-represented in patients with progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Using single nucleotide polymorphisms (SNPs), we mapped LD in the regions flanking MAPT and have established the maximum extent of the haplotype block on chromosome 17q21.31 as a region covering
Article
The structure of the tau haplotype in controls and in progressive supranuclear palsy
2 Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Building 10, Bethesda, MD 20892, USA
3 Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N 3BG, UK
![]()
Abstract
2 million base pairs (Mb). This gene-rich region extends centromerically beyond the corticotrophin releasing hormone receptor 1 gene (CRHR1) to a region of
400 kb where there is a complete loss of LD. The telomeric end is defined by a
150 Kb region just beyond the WNT3 gene. We show that the entire, fully extended H1 haplotype is associated with PSP, which implicates several other genes in addition to MAPT, as candidate pathogenic loci.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. E. Tobin, J. C. Latourelle, M. F. Lew, C. Klein, O. Suchowersky, H. A. Shill, L. I. Golbe, M. H. Mark, J. H. Growdon, G. F. Wooten, et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study Neurology, July 1, 2008; 71(1): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. K. Kauwe, C. Cruchaga, K. Mayo, C. Fenoglio, S. Bertelsen, P. Nowotny, D. Galimberti, E. Scarpini, J. C. Morris, A. M. Fagan, et al. Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition PNAS, June 10, 2008; 105(23): 8050 - 8054. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Laws, R. Perneczky, A. Drzezga, J. Diehl-Schmid, B. Ibach, J. Bauml, T. Eisele, H. Forstl, A. Kurz, and M. Riemenschneider Association of the Tau Haplotype H2 With Age at Onset and Functional Alterations of Glucose Utilization in Frontotemporal Dementia Am J Psychiatry, October 1, 2007; 164(10): 1577 - 1584. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Dawson, V. Cantillana, L. Chen, and M. P. Vitek The Tau N279K Exon 10 Splicing Mutation Recapitulates Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 Tauopathy in a Mouse Model J. Neurosci., August 22, 2007; 27(34): 9155 - 9168. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Sundar, C.-E. Yu, W. Sieh, E. Steinbart, R. M. Garruto, K. Oyanagi, U.-K. Craig, T. D. Bird, E. M. Wijsman, D. R. Galasko, et al. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia Hum. Mol. Genet., February 1, 2007; 16(3): 295 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Caffrey, C. Joachim, S. Paracchini, M. M. Esiri, and R. Wade-Martins Haplotype-specific expression of exon 10 at the human MAPT locus Hum. Mol. Genet., December 15, 2006; 15(24): 3529 - 3537. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Pittman, H.-C. Fung, and R. de Silva Untangling the tau gene association with neurodegenerative disorders Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R188 - R195. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rademakers, S. Melquist, M. Cruts, J. Theuns, J. Del-Favero, P. Poorkaj, M. Baker, K. Sleegers, R. Crook, T. De Pooter, et al. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy Hum. Mol. Genet., November 1, 2005; 14(21): 3281 - 3292. [Abstract] [Full Text] [PDF] |
||||
![]() |
A M Pittman, A J Myers, P Abou-Sleiman, H C Fung, M Kaleem, L Marlowe, J Duckworth, D Leung, D Williams, L Kilford, et al. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration J. Med. Genet., November 1, 2005; 42(11): 837 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. Myers, M. Kaleem, L. Marlowe, A.M. Pittman, A.J. Lees, H.C. Fung, J. Duckworth, D. Leung, A. Gibson, C.M. Morris, et al. The H1c haplotype at the MAPT locus is associated with Alzheimer's disease Hum. Mol. Genet., August 15, 2005; 14(16): 2399 - 2404. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cruts, R. Rademakers, I. Gijselinck, J. van der Zee, B. Dermaut, T. de Pooter, P. de Rijk, J. Del-Favero, and C. van Broeckhoven Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region Hum. Mol. Genet., July 1, 2005; 14(13): 1753 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Williams, R. de Silva, D. C. Paviour, A. Pittman, H. C. Watt, L. Kilford, J. L. Holton, T. Revesz, and A. J. Lees Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism Brain, June 1, 2005; 128(6): 1247 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hinds, L. L. Stuve, G. B. Nilsen, E. Halperin, E. Eskin, D. G. Ballinger, K. A. Frazer, and D. R. Cox Whole-Genome Patterns of Common DNA Variation in Three Human Populations Science, February 18, 2005; 307(5712): 1072 - 1079. [Abstract] [Full Text] [PDF] |
||||







